Furthermore, targeting ELTD1 with polyclonal (pAb), monoclonal (mAb), or single-chain variable fragment region (scFv) antibodies, showed a drastic decrease of Notch1 expression levels in a GBM mouse model [Figure 2I for mAb][74,76]. The gene discussed is ADGRL4; the disease is glioblastoma.